Literature DB >> 16734622

Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen.

E Paulovicová1, E Machová, A Hostacká, S Bystrický.   

Abstract

Host protection by humoral immunity against Vibrio cholerae O1 confers lipopolysaccharide (LPS)-specific vibriocidal antibodies. Levels of relevant specific antibodies are closely related to complement-mediated inactivation of the vibrios inoculum, especially on the mucosal surface of intestine. We have tested complex V. cholerae O1 Ogawa-detoxified lipopolysaccharide (dLPS) conjugates. The first conjugate contained glucan both as the immunomodulator and the matrix; the second conjugate contained immunologically inert amylose as matrix. Both d-LPS conjugates contain multiply attached dLPS antigen. These conjugates elicited a statistically significant increase of antigen-specific IgG levels in mice (P<0.001 and P<0.05, respectively). The specific anti-conjugate IgG and IgA response after the second (booster) dose were significantly higher compared to pre-immune and whole-cell response. The most effective vibriocidal activity was observed in the case of conjugate, with glucan as the matrix. The highest correlation was found between vibriocidal activity and specific IgG2b (r=0.765) and IgA (r=0.887) sera levels. The determination of specific IgG subclasses and IgG2a + 2b/IgG1 ratio revealed a dominant T(H)1 cell response crucial for effective vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16734622      PMCID: PMC1941987          DOI: 10.1111/j.1365-2249.2006.03077.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Decrease in effectiveness of routine surveillance of Haemophilus influenzae disease after introduction of conjugate vaccine: comparison of routine reporting with active surveillance system.

Authors:  B Olowokure; J Hawker; I Blair; N Spencer
Journal:  BMJ       Date:  2000-09-23

2.  Synthesis of eight glycosides of hexasaccharide fragments representing the terminus of the O-polysaccharide of Vibrio cholerae O:1, serotype Inaba and Ogawa, bearing aglycons suitable for linking to proteins.

Authors:  Y Ogawa; P S Lei; P Kovác
Journal:  Carbohydr Res       Date:  1996-10-31       Impact factor: 2.104

3.  Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.

Authors:  F Qadri; F Ahmed; M M Karim; C Wenneras; Y A Begum; M Abdus Salam; M J Albert; J R McGhee
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Intestinal immunoglobulin production after oral cholera vaccination in patients with IgA deficiency with or without IgG subclass deficiency.

Authors:  D E Nilssen; V Friman; K Theman; J Björkander; A Kilander; J Holmgren; L A Hanson; P Brandtzaeg
Journal:  Immunodeficiency       Date:  1993

5.  Application of Candida solubilized cell wall beta-glucan in antitumor immunotherapy against P815 mastocytoma in mice.

Authors:  Kazuhiro Tokunaka; Naohito Ohno; Yoshiyuki Adachi; Noriko N Miura; Toshiro Yadomae
Journal:  Int Immunopharmacol       Date:  2002-01       Impact factor: 4.932

6.  Th1/Th2-Balancing immunomodulating activity of gel-forming (1-->3)-beta-glucans from fungi.

Authors:  Y Suzuki; Y Adachi; N Ohno; T Yadomae
Journal:  Biol Pharm Bull       Date:  2001-07       Impact factor: 2.233

7.  Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity.

Authors:  E Tsiapali; S Whaley; J Kalbfleisch; H E Ensley; I W Browder; D L Williams
Journal:  Free Radic Biol Med       Date:  2001-02-15       Impact factor: 7.376

8.  Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier.

Authors:  Anatoly Chernyak; Seiichi Kondo; Terri K Wade; Michael D Meeks; Pedro M Alzari; Jean-Michel Fournier; Ronald K Taylor; Pavol Kovác; William F Wade
Journal:  J Infect Dis       Date:  2002-03-19       Impact factor: 5.226

9.  Preparation of a subcellular conjugate with the lipopolysaccharide from Vibrio cholerae 01 using beta-D-glucan as matrix.

Authors:  Eva Machová; Slavomír Bystrický; Anna Gáliková; Grigorij Kogan
Journal:  Eur J Med Chem       Date:  2002-08       Impact factor: 6.514

10.  Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE).

Authors:  Jeff Alexander; Marie-France del Guercio; Barbara Frame; Ajesh Maewal; Alessandro Sette; Moon H Nahm; Mark J Newman
Journal:  Vaccine       Date:  2004-06-23       Impact factor: 3.641

View more
  1 in total

1.  Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba.

Authors:  Cyrille Grandjean; Alain Boutonnier; Bruno Dassy; Jean-Michel Fournier; Laurence A Mulard
Journal:  Glycoconj J       Date:  2008-07-23       Impact factor: 2.916

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.